Xenon Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Corporate Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Xenon Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Corporate Update

Xenon Pharmaceuticals (XENE) Misses Q2 EPS by 3c

August 11, 2021 4:04 PM EDT

Xenon Pharmaceuticals (NASDAQ: XENE) reported Q2 EPS of ($0.51), $0.03 worse than the analyst estimate of ($0.48). Revenue for the quarter came in at $2.2 million versus the consensus estimate of $2.33 million.

Mr. Ian Mortimer, Xenons President and Chief Executive Officer stated, We continue to make strong progress across our portfolio of... More